-
公开(公告)号：US12109182B2
公开(公告)日：2024-10-08
申请号：US17367206
申请日：2021-07-02
Applicant: AXCESS GLOBAL SCIENCES, LLC
Inventor： Ryan Lowery , Jacob Wilson , Terry LaCore
IPC: A61K31/19 , A61K9/00 , A61K31/522 , A61P3/04 , A61P25/28
CPC classification number: A61K31/19 , A61K9/0053 , A61K31/522 , A61P3/04 , A61P25/28
Abstract: In various implementations, beta-hydroxybutyrate, related compounds, and/or one or more other compounds may be administered to an individual to cause weight loss, weight maintenance, elevate blood ketone levels, maintain blood ketone levels, reduce blood glucose levels, maintain blood glucose levels, improve energy, focus, mood, cognitive function, or aide with neurological or inflammatory disorders and/or combinations thereof.
-
公开(公告)号：US11969411B2
公开(公告)日：2024-04-30
申请号：US17341312
申请日：2021-06-07
Applicant: AXCESS GLOBAL SCIENCES, LLC
Inventor： Ryan Lowery , Jacob Wilson , Terry LaCore
IPC: A61K31/4355 , A61K9/107 , A61K31/00 , A61K31/19 , A61K31/4745 , A61K36/889 , A61K45/06 , A61K47/44 , A61K47/69 , A61P3/08 , A61K9/00
CPC classification number: A61K31/4355 , A61K9/1075 , A61K31/00 , A61K31/19 , A61K31/4745 , A61K36/889 , A61K45/06 , A61K47/44 , A61K47/6911 , A61P3/08 , A61K9/0053
Abstract: In various implementations, berberine metabolites, such as dihydroberberine and/or tetrahydroberberine, may be administered to manage blood glucose levels, increase ketone levels (e.g., blood concentration of ketones), and/or for therapeutic purposes in humans. The administration of a pharmaceutically effective amount of berberine metabolites, such as dihydroberberine, may reduce fasting blood glucose levels, improve glucose tolerance, and/or improve blood ketone response. In some implementations, berberine metabolites may be administered with one or more other compounds.
